A system for mid-intensity, non-ablative acoustic treatment of injured tissue is disclosed. The system produces a non-ablative therapeutic ultrasound beam profile within the injured tissue. The system terminates energy delivery if a motion sensor senses movement speed below a speed threshold. The non-ablative therapeutic ultrasound beam profile provides substantially uniform heating throughout a treatment volume. The heating is non-ablative and triggers a healing response in the injured tissue.

A surgical instrument includes a shaft assembly, an ultrasonic blade, and a cleaning device. The shaft assembly includes a first tube and an acoustic waveguide. The first tube has a first inner diameter and a distal end. The waveguide has a first outer diameter. The waveguide extends within the first tube. The first outer diameter of the acoustic waveguide and the first inner diameter of the first tube together define a gap. The ultrasonic blade extends distally from the distal end of the first tube. The acoustic waveguide is configured to communicate ultrasonic energy to the ultrasonic blade. The cleaning device is configured to actuate within the gap to thereby clean at least a portion of the shaft assembly and/or at least a portion of the ultrasonic blade.

Disclosed are devices suitable for treatment of subcutaneous tissue by transdermally-inducing ultrasonic vibrations in subcutaneous tissue and/or transdermally delivering energy with electromagnetic radiation such as light to subcutaneous tissue. In some embodiments, the treatment of subcutaneous tissue is effective in reducing the amount of subcutaneous fat therein. In some embodiments, transdermal radiation-delivery of energy and transdermal induction of ultrasonic vibrations in subcutaneous tissue can be performed simultaneously, alternatingly or in an unrelated fashion. In some embodiments, the device simultaneously transdermally-induces both ultrasonic transverse and ultrasonic longitudinal vibrations in subcutaneous tissue.

In a wave focusing device and a wave emitting device having the wave focusing device, the wave focusing device has a plurality of filters and focuses a wave by a phase overlap. The plurality of filters includes a first filter formed on a substrate, a second filter formed on the substrate and overlapping with the first filter in a first area, and a third filter formed on the substrate and overlapping with the second filter in a second area. A size of the first area is substantially same as that of the second area. A first portion of the second filter in the first area is inverted to a second portion of the second filter in the second area, with respect to a first axis. A wave passing through the wave focusing device is focused at a center of each of the first, second and third filters.

A phacoemulsification apparatus includes an ultrasound transmitter, an irrigation-aspiration tool, a robotic arm, and a processor. The ultrasound transmitter is configured to generate and focus an ultrasound beam into a lens capsule of an eye of a patient, to emulsify a lens of the eye. The irrigation-aspiration tool having a distal end including an outlet of an irrigation channel for flowing irrigation fluid into the lens capsule, and an inlet of an aspiration channel for removing material from the lens capsule. The robotic arm is configured to move the distal end of the irrigation-aspiration tool inside the lens capsule. The processor is configured to control the ultrasound transmitter to irradiate one or more target locations in the eye capsule with the focused ultrasound beam, and control the robotic arm to move the distal end of the irrigation-aspiration tool in coordination with the target locations irradiated by the ultrasound transmitter.

An ultrasound therapy system and method is provided that provides directional, focused ultrasound to localized regions of tissue within body joints, such as spinal joints. An ultrasound emitter or transducer is delivered to a location within the body associated with the joint and heats the target region of tissue associated with the joint from the location. Such locations for ultrasound transducer placement may include for example in or around the intervertebral discs, or the bony structures such as vertebral bodies or posterior vertebral elements such as facet joints. Various modes of operation provide for selective, controlled heating at different temperature ranges to provide different intended results in the target tissue, which ranges are significantly affected by pre-stressed tissues such as in-vivo intervertebral discs. In particular, treatments above 70 degrees C., and in particular 75 degrees C., are used for structural remodeling, whereas lower temperatures achieve other responses without appreciable remodeling.

A method of killing AGE-modified cells comprises applying ultrasound to a subject and administering to the subject a composition comprising an anti-AGE antibody. The applying of ultrasound may occur before or after the administering of the anti-AGE antibody. The AGE-modified cells may be in a restricted site.

A catheter is disclosed that may be used in a minimally invasive internal treatment (e.g., sonodynamic therapy). The catheter can include a housing, a portion of which may be positioned in contact with internal tissue of a patient during a minimally invasive sonodynamic or photo-sonodynamic therapy procedure. The catheter may include multiple electrically independent ultrasound transducers. The ultrasound transducers can be configured to emit ultrasound energy into the internal tissue of the patient. The ultrasound energy that is emitted from the catheter may reach a target tissue depth at a relatively low temporal average intensity (e.g., less than 50 W/cm2). Such ultrasound energy may activate the sensitizer.

Various approaches to focusing an ultrasound transducer includes causing the ultrasound transducer to transmit ultrasound waves to the target region; causing the detection system to indirectly measure the focusing properties; and based at least in part on the indirectly measured focusing properties, adjusting a parameter value associated with at least one of the transducer elements so as to achieve a target treatment power at the target region.

Various approaches for microbubble-enhanced ultrasound treatment of target tissue include receiving a desired characteristic of the microbubbles for treating the target tissue; causing the microbubbles to be dispensed from the administration device; and comparing a characteristic of the dispensed microbubbles to the desired characteristic so as to validate a match therebetween.